Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT)

Transfusion and Apheresis Science

Volumn 36, Issue 1, 2007, Pages 23-29

  Ergene, Ülkü ^a   Çaǧirgan, Seçkin ^b   Pehlivan, Mustafa ^c   Yilmaz, Mümtaz ^b   Tombuloǧlu, Murat ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Autologous stem cell transplantation; CD34+ cells; Engraftment

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; MELPHALAN; MESNA; PHENYTOIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; ENGRAFTMENT; FEBRILE NEUTROPENIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HODGKIN DISEASE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYCOSIS; NEUTROPHIL; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; CARMUSTINE; CYTARABINE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; KINETICS; MALE; MELPHALAN; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PODOPHYLLOTOXIN; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 33847362320     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.08.009     Document Type: Article

References (20)

1. Beutler E., Lichtman M.A., Kipps T.J., Seligsohn U., Kaushansky K., and Prchal J.T. Principle of hematopoietic cell transplantation. In: Negrin R.S., and Blume K.G. (Eds). William Hematol. 7th ed. (2006), McGraw-Hill 301-322
2. Lee R.G., Foerster J., Lukens J., Paraskevas F., Greer P.J., and Rodgers M.G. Hematol Malignancies. 10th ed. Wintrobe's Clin Hematol (1999), Mass Publishing Co. p. 1993-2725
3. Craig W., Kay R., Cutler R.L., and Lansdorp P.M. Expression of thy-1 on human hematopoietic progenitor cells. J Exp Med 177 (1993) 1331
4. Unhida N., Combs J., Chen S., et al. Primitive human hematopoietic cells displaying differential efflux of the rhodamine-123 dye have distinct biological activities. Blood 88 (1996) 1297
5. Bensinger W.I., Appelbaum F.R., Rowley S., et al. Factors that influence collection and engraftment of autologous peripheral blood stem cells. J Clin Oncol 13 (1995) 2547-2555
6. Schwartzberg L., Birch R., Blanco R., et al. Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transpl 11 (1993) 369-374
7. Haas R., Witt B., Möhle R., Goldschmidt H., Hohaus S., Fruehauf S., Wannenmacher M., and Hunstein W. Sustained long-term hematopoiesis after myeloablastive therapy with peripheral blood progenitor cell support. Blood 85 (1995) 3754-3761
8. Pavlovsky S., Koziner B., Milone G., et al. Multivariate analyses of prognostic factors associated with hematopoietic recovery in autograft patients with different sources of progenitor cells. Ann Oncol 7 (1996) 719-724
9. Lowenthal R.M., Faberes C., Marit G., et al. Factors influencing haemopoetic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience. Bone Marrow Transpl 22 (1998) 763-770
10. Mounier N., Larghero J., Manson J., Brice P., et al. Long term hematologic recovery after autologous stem cell transplantation in lymphoma patients: impact of the number of prefreeze and post-thaw CD34+ cells. Bull Cancer 92 3 (2005) E31-E38
11. Jillella A.P., and Ustun C. What is the optimum number of CD34+ peripheral blood stem cells for an autologous transplant?. Stem Cells Dev 13 6 (2004) 598-606
12. Bensinger W.I., Longin K., Appelbaum F., et al. Peripheral blood stem cell (PBSCs) collected after recombinant granulacyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Brit J Haematol 87 (1994) 825-831
13. Palomera L., Domingo(2) J.M., Moreno J.A., Sola C., Arruga A., Gavin O., et al. Clinical significance of CD34+ cell dose on the hematologic recovery in autologous peripheral blood stem cell transplantation. Hematol J 1 suppl.1 (2001) 210
14. Carral A., Rubia J., Martin G., Martinez J., Sanz G., Jarque I., et al. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transpl 29 (2002) 825-832
15. To L.B., Haylock D.N., Dyson P.G., et al. An unusual pattern of hemopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood. Bone Marrow Transpl 6 (1990) 109-114
16. Demirer T., Buckner C.D., Appelbum F.R., et al. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cell in patients with acute myelogenous leukemia. Bone Marrow Transpl 15 (1995) 915-922
17. Gondo H., Harada M., Miyamoto T., et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transpl 20 (1997) 821-826
18. Martin C., Torres A., Leon A., et al. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-SCF in AML in first complete remission. Role of intensification therapy in outcome. Bone Marrow Transpl 21 (1998) 375-382
19. Vellenga E., Van Putten W.L., Boogaerts M.A., et al. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia. Bone Marrow Transpl 23 (1999) 1279-1282
20. Ringden O., Labopin M., Gorin N.C., Le Blanc K., et al. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the acute leukemia working party of the European group for blood and marrow transplantation. J Clin Oncol 3 (2004) 416-423